LOM
SCMP

Loeb Offshore Management’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Loeb Offshore Management’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-35,489
Closed -$221K – 260
2013
Q3 		$221K Buy
+35,489
New +$222K 0.07% 184

Other funds holding SCMP

VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $851M AUM 5.13% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Loeb Offshore Management's SCMP Position: Q4 2013 in Review

Loeb Offshore Management sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q4 2013, closing a stake of 35,489 shares — an estimated $221K sold.

Loeb Offshore Management first reported a position in SCMP in Q3 2013 and held it in 1 quarter. The position peaked at $221K in Q3 2013. 74 funds tracked by Wall St. Rank hold SCMP as of Q4 2013.

  • Loeb Offshore Management reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q4 2013 after selling out during the quarter.
  • Loeb Offshore Management sold 35,489 Sucampo Pharmaceuticals, Inc. shares in Q4 2013, an estimated $221K.
  • Loeb Offshore Management first reported a position in Sucampo Pharmaceuticals, Inc. in Q3 2013 and held it in 1 quarter.
  • Loeb Offshore Management's Sucampo Pharmaceuticals, Inc. position peaked at $221K in Q3 2013.
  • 74 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q4 2013.

Based on Loeb Offshore Management's 13F filing for Q4 2013, filed 14 Feb 2014.